Unit Dose Packaging Market - Global Forecast To 2029
| 出版年月 | 2024年8月 |
| ページ数 | 230 |
| 図表数 | 218 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The unit dose packaging market is projected to grow from USD 29.1 Billion in 2024 to USD 43.8 Billion by 2029, at a CAGR of 8.5% during the forecast period.
単位用量包装市場は、予測期間中に8.5%のCAGRで、2024年の291億米ドルから2029年までに438億米ドルに成長すると予測されています。
The rising demand for blister packaging is significantly driving the growth of the unit dose packaging market due to its key advantages in ensuring medication safety, accuracy, and convenience. Blister packaging, which encloses individual doses in plastic and foil compartments, is widely used in the pharmaceutical industry for its ability to protect medications from moisture and light, preserving their potency. Medications such as birth control pills and over-the-counter pain relievers are often packaged in blister packs, which help patients easily track doses and adhere to their medication schedules. This method not only improves patient compliance by clearly separating and labeling each dose but also reduces medication errors. The convenience of blister packaging makes it ideal for individuals with busy lifestyles, further boosting its popularity. The healthcare sector’s emphasis on patient safety and adherence, along with the practical benefits of blister packaging, continues to drive its adoption across various industries.
“By Form, solid is the second largest market share for unit dose packaging during forecast period.”
Solid unit dose packaging accounts for a substantial share, estimated at 30-35%. This packaging format is widely used in pharmaceuticals, where blister packs for tablets and capsules are common. Products such as ibuprofen, antihistamines, and multivitamins are frequently packaged in this way to ensure precise dosing and protection from environmental factors. In the nutraceutical sector, solid unit dose packaging is employed for vitamins and dietary supplements like Omega-3 capsules, providing convenience and accurate dosing. Cosmetics also use solid unit dose formats for items such as single-use capsules containing skincare treatments and face masks. The growth of solid unit dose packaging is largely driven by its extensive application in the pharmaceutical industry.
“By Material Type, plastic account for largest market share for unit dose packaging during forecast period.”
Plastic, a synthetic material made by linking monomers in various configurations, offers unique properties like flexibility, durability, and resistance to degradation. In the unit dose packaging industry, plastics such as polyethylene (PE), polypropylene (PP), and polyvinyl chloride (PVC) are valued for their effective barriers against moisture, light, gases, and contaminants. These materials are crucial in healthcare and pharmaceuticals due to their precise dosing capabilities, tamper-evident seals, and easy-open features, ensuring secure and user-friendly medication delivery. Plastic packaging is cost-effective, reducing waste and meeting stringent sterility and regulatory standards, thus maintaining medication safety and efficacy. Compared to glass and aluminum, plastics are preferred for their lightweight nature, impact resistance, and design flexibility, accommodating specialized forms and sizes for various applications.
“By Product Type, blister pack account for largest share during forecast period.”
Blister packs consist of a thermoformed plastic cavity and a flexible top, designed to protect contents from moisture, gases, light, and physical damage, thereby preserving their integrity and extending shelf life. They securely house individual doses of medications, vitamins, supplements, and other products. To address sustainability concerns, modern blister packs use eco-friendly materials and efficient designs to minimize environmental impact while meeting market needs in pharmaceuticals, nutraceuticals, and medical devices. Blister packs contribute to packaging efficiency by enhancing product protection, ensuring precise dosing, and increasing safety. Leading companies such as Amcor plc, Constantia Flexibles, and West Pharmaceutical Services are incorporating smart technologies like RFID (Radio Frequency Identification) and NFC (Near Field Communication) into blister packs to improve tracking, authentication, and real-time monitoring. Additionally, Klockner Pentaplast offers advanced films with high clarity, autoclavable laminate, and robust barriers against moisture and package leaching. These films are ideal for hot-fill liquids and new dosage forms, providing customizable moisture protection, high heat stability, quick release, and excellent odor and flavor retention.
“By End-Use Industry, Pharmaceutical End-use Industry Segment Accounted For largest share during forecast period.”
Unit dose packaging is crucial in the pharmaceutical industry for distributing precise doses of medications, vitamins, oral liquids, and injectables. It ensures that each dose is securely contained in a sealed package, such as vials, ampoules, or blister packs. Technologies like Blow-Fill-Seal (BFS) streamline the sterile packaging process, minimizing contamination risks and enhancing product safety. The trend towards prefilled syringes and auto-injectors provides accurate dosing and improved patient compliance with added safety features. Innovations in sensors and indicators monitor environmental conditions to maintain medication efficacy. The shift towards sustainable materials and optimized packaging sizes highlights the industry’s commitment to reducing environmental impact while enhancing patient safety and dosing accuracy.
“North America is accounted larget market for Unit dose packaging in 2023.”
The North America region is accounted larget in the unit dose packaging market. This growth encompasses countries like US, Canada, and Mexico.
The unit dose packaging market in North America is being propelled by various factors. In North America, the pharmaceutical industry heavily relies on unit dose packaging for its precision, patient compliance, and protection against contamination and tampering. This demand is driven by a focus on patient-centric solutions, the need for accurate dosing to reduce errors, and the convenience of use. The aging population and high prevalence of chronic diseases further boost the need for pharmaceuticals and healthcare services. According to pharma association, in 2023, the industry invested around USD 90 billion in R&D, reflecting its growth. Stringent regulations by the FDA and Health Canada ensure compliance with safety and quality standards, influencing packaging choices. Despite significant growth, challenges such as increased competition, innovation, and environmental regulations pose constraints to the market.
In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the unit dose packaging market.
- By Company Type: Tier 1: 40%, Tier 2: 25%, and Tier 3: 35%
- By Designation: C Level: 35%, Director Level: 30%, and Others: 35%
- By Region: North America: 25%, Europe: 20%, APAC: 45%, Middle East & Africa: 5%, and South America: 5%
Companies Covered: The global unit dose packaging market comprises major manufacturers, such as Pfizer Inc. (US), Amcor Plc (Switzerland), Corning Incorporated (US), West Pharmaceutical Services (US), Stevanato Group (Italy), Gerresheimer AG (Germany), SCHOTT (Germany), Nipro (Japan), Constantia Flexibles (Austria), and Klöckner Pentaplast (UK), among others.
Research Coverage
The market study covers the unit dose packaging market across various segments. It aims at estimating the market size and the growth potential of this market across different segments based on form, material type, product type, end-use industry, and region. The study also includes an in-depth competitive analysis of key players in the market, their company profiles, key observations related to their products and business offerings, recent developments undertaken by them, and key growth strategies adopted by them to improve their position in the unit dose packaging market.
Key Benefits of Buying the Report
The report is expected to help the market leaders/new entrants in this market share the closest approximations of the revenue numbers of the overall unit dose packaging market and its segments and sub-segments. This report is projected to help stakeholders understand the competitive landscape of the market, gain insights to improve the position of their businesses, and plan suitable go-to-market strategies. The report also aims to help stakeholders understand the pulse of the market and provides them with information on the key market drivers, challenges, and opportunities.
The report provides insights on the following pointers:
Analysis of key drivers (Thriving Pharmaceutical Sector and surge in healthcare expenditure, Rising demand for blister packaging, and Consumer preference for convenience and portability driving demand for unit dose packaging), restraints (The setup and maintenance of unit dose packaging machines and Environmental concerns), opportunities (Increasing demand for primary pharmaceutical packaging and Market expansion in nutraceuticals and cosmetics) and challenges (Technological challenges in the unit dose packaging market and High initial investment).
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the unit dose packaging market
- Market Development: Comprehensive information about lucrative markets – the report analyses the unit dose packaging market across varied regions
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the unit dose packaging market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Pfizer Inc. (US), Amcor Plc (Switzerland), Corning Incorporated (US), West Pharmaceutical Services (US), Stevanato Group (Italy), Gerresheimer AG (Germany), SCHOTT (Germany), Nipro (Japan), Constantia Flexibles (Austria), and Klöckner Pentaplast (UK), among others in the unit dose packaging market. The report also helps stakeholders understand the pulse of the unit dose packaging market and provides them with information on key market drivers, restraints, challenges, and opportunities.
Table of Contents
1 INTRODUCTION 22
1.1 STUDY OBJECTIVES 22
1.2 MARKET DEFINITION 22
1.2.1 INCLUSIONS AND EXCLUSIONS 23
1.3 STUDY SCOPE 24
1.3.1 UNIT DOSE PACKAGING MARKET SEGMENTATION 24
1.3.2 YEARS CONSIDERED 25
1.3.3 CURRENCY CONSIDERED 25
1.3.4 UNITS CONSIDERED 25
1.4 LIMITATIONS 25
1.5 STAKEHOLDERS 26
2 RESEARCH METHODOLOGY 27
2.1 RESEARCH DATA 27
2.1.1 SECONDARY DATA 28
2.1.1.1 Key data from secondary sources 28
2.1.2 PRIMARY DATA 29
2.1.2.1 Key data from primary sources 29
2.1.2.2 Key primary participants 30
2.1.2.3 Key industry insights 30
2.1.2.4 Breakdown of interviews with experts 31
2.2 MARKET SIZE ESTIMATION 31
2.2.1 BOTTOM-UP APPROACH 32
2.2.2 TOP-DOWN APPROACH 32
2.3 FORECAST NUMBER CALCULATION 33
2.4 DATA TRIANGULATION 35
2.5 FACTOR ANALYSIS 36
2.6 ASSUMPTIONS 36
2.7 RESEARCH LIMITATIONS AND RISKS 37
3 EXECUTIVE SUMMARY 38
4 PREMIUM INSIGHTS 42
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN UNIT DOSE PACKAGING MARKET 42
4.2 NORTH AMERICA: UNIT DOSE PACKAGING MARKET,
BY END-USE INDUSTRY AND COUNTRY 43
4.3 NORTH AMERICA UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE 43
4.4 NORTH AMERICA UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY 44
4.5 UNIT DOSE PACKAGING MARKET, BY KEY COUNTRY 44
5 MARKET OVERVIEW 45
5.1 INTRODUCTION 45
5.2 MARKET DYNAMICS 46
5.2.1 DRIVERS 46
5.2.1.1 Thriving pharmaceutical sector and surge in healthcare expenditure 46
5.2.1.2 Rising demand for blister packaging 47
5.2.1.3 Consumer preference for convenience and portability 47
5.2.2 RESTRAINTS 48
5.2.2.1 Substantial capital investment required for setup and maintenance of unit dose packaging machines 48
5.2.2.2 Environmental concerns 48
5.2.3 OPPORTUNITIES 49
5.2.3.1 Increasing demand for primary pharmaceutical packaging 49
5.2.3.2 Market expansion in nutraceuticals and cosmetics 49
5.2.4 CHALLENGES 50
5.2.4.1 Technological challenges 50
5.2.4.2 High initial investment 50
6 INDUSTRY TRENDS 51
6.1 PORTER’S FIVE FORCES ANALYSIS 51
6.1.1 THREAT OF NEW ENTRANTS 52
6.1.2 THREAT OF SUBSTITUTES 52
6.1.3 BARGAINING POWER OF SUPPLIERS 52
6.1.4 BARGAINING POWER OF BUYERS 53
6.1.5 INTENSITY OF COMPETITIVE RIVALRY 53
6.2 VALUE CHAIN ANALYSIS 54
6.3 TRADE ANALYSIS 55
6.3.1 EXPORT SCENARIO 55
6.3.2 IMPORT SCENARIO 56
6.4 IMPACT OF GEN AI ON UNIT DOSE PACKAGING 57
6.4.1 INTEGRATING AI IN UNIT DOSE PACKAGING 57
6.4.2 BEST PRACTICES TO LEVERAGE AI FOR UNIT DOSE PACKAGING MARKET 57
6.4.3 USE CASES OF GENERATIVE AI IN UNIT DOSE PACKAGING MARKET 58
6.4.3.1 Future of generative AI in unit dose packaging market 58
6.5 MACROECONOMIC INDICATORS 59
6.5.1 GLOBAL GDP OUTLOOK 59
6.6 TECHNOLOGY ANALYSIS 60
6.6.1 KEY TECHNOLOGIES 61
6.6.1.1 Blister packaging 61
6.6.1.2 Strip packaging 61
6.6.1.3 Blow-Fill-Seal 61
6.6.2 COMPLEMENTARY TECHNOLOGIES 62
6.6.2.1 Smart packaging 62
6.6.2.2 Barrier and coating 63
6.7 TARIFF AND REGULATORY LANDSCAPE 63
6.7.1 TARIFF RELATED TO UNIT DOSE PACKAGING MARKET 63
6.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64
6.8 CASE STUDY ANALYSIS 67
6.9 TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS 68
6.10 KEY CONFERENCES & EVENTS IN 2024–2025 69
6.11 KEY STAKEHOLDERS AND BUYING CRITERIA 70
6.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 70
6.11.2 BUYING CRITERIA 71
6.12 ECOSYSTEM ANALYSIS 72
6.13 PATENT ANALYSIS 73
6.13.1 INTRODUCTION 73
6.13.2 METHODOLOGY 73
6.14 PRICING ANALYSIS 78
6.14.1 AVERAGE SELLING PRICE OF PHARMACEUTICAL PACKAGING, BY REGION 78
6.14.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY MATERIAL TYPE 79
6.14.3 INVESTMENT AND FUNDING SCENARIO 80
7 UNIT DOSE PACKAGING MARKET, BY FORM 81
7.1 INTRODUCTION 82
7.2 LIQUID 83
7.3 SOLID 83
7.4 POWDER 83
7.5 GEL 83
8 UNIT DOSE PACKAGING MARKET, BY MATERIAL TYPE 84
8.1 INTRODUCTION 85
8.2 PLASTIC 86
8.2.1 POLYVINYL CHLORIDE 86
8.2.2 POLYETHYLENE 86
8.2.3 POLYPROPYLENE 87
8.2.4 POLYETHYLENE TEREPHTHALATE 87
8.2.5 OTHER PLASTIC FILMS 87
8.3 GLASS 88
8.4 PAPER & PAPERBOARD 88
8.5 ALUMINUM 88
8.6 OTHER MATERIAL TYPES 89
9 UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE 90
9.1 INTRODUCTION 91
9.2 BLISTER PACKS 92
9.2.1 ENSURE DRUG DOSING ACCURACY AND INCREASED SAFETY 92
9.3 SACHETS & STRIP PACKS 92
9.3.1 MAINTAIN PRODUCT FRESHNESS AND QUALITY 92
9.4 AMPOULES & VIALS 93
9.4.1 USED FOR STORING AND DISPENSING LIQUID PHARMACEUTICALS 93
9.5 OTHER PRODUCT TYPES 93
10 UNIT DOSE PACKAGING, BY END-USE INDUSTRY 94
10.1 INTRODUCTION 95
10.2 PHARMACEUTICALS 96
10.2.1 INCREASED DEMAND FOR PREFILLED SYRINGES AND AUTO-INJECTORS 96
10.3 COSMETICS & PERSONAL CARE 96
10.3.1 EXTENDING SHELF LIFE OF BEAUTY PRODUCTS 96
10.4 NUTRACEUTICALS 97
10.4.1 ADMINISTRATION OF PRECISE DOSAGE AND CONSUMER COMPLIANCE 97
10.5 OTHER END-USE INDUSTRIES 97
11 UNIT DOSE PACKAGING MARKET, BY REGION 98
11.1 INTRODUCTION 99
11.2 ASIA PACIFIC 100
11.2.1 CHINA 103
11.2.1.1 Rising investments in biologics and biosimilar drug research to drive market 103
11.2.2 INDIA 104
11.2.2.1 Large domestic consumption and export of generic drugs to drive market 104
11.2.3 JAPAN 105
11.2.3.1 Surge in aging population to drive demand for medications 105
11.2.4 SOUTH KOREA 106
11.2.4.1 Growth of cosmetic & personal care industries to drive market 106
11.2.5 REST OF ASIA PACIFIC 107
11.3 EUROPE 108
11.3.1 GERMANY 110
11.3.1.1 Advanced healthcare infrastructure and emphasis on patient-centric care to drive market 110
11.3.2 FRANCE 111
11.3.2.1 Surge in demand for generic drugs to drive market 111
11.3.3 ITALY 113
11.3.3.1 Growing exports of pharmaceutical products to boost market 113
11.3.4 UK 114
11.3.4.1 Innovations in drug manufacturing to drive market 114
11.3.5 SPAIN 115
11.3.5.1 Growth of cosmetic & personal care industry to drive market 115
11.3.6 REST OF EUROPE 116
11.4 NORTH AMERICA 117
11.4.1 US 119
11.4.1.1 Increasing demand for RFID integration and smart packaging to drive market 119
11.4.2 CANADA 120
11.4.2.1 Rising demand for precise packaging to drive market 120
11.4.3 MEXICO 121
11.4.3.1 Technological advancements and packaging innovations to boost market 121
11.5 SOUTH AMERICA 122
11.5.1 BRAZIL 124
11.5.1.1 Increased healthcare awareness and substantial investment to drive market 124
11.5.2 ARGENTINA 125
11.5.2.1 Innovations in packaging to drive market 125
11.5.3 REST OF SOUTH AMERICA 126
11.6 MIDDLE EAST & AFRICA 127
11.6.1 GCC COUNTRIES 129
11.6.1.1 Saudi Arabia 129
11.6.1.1.1 Saudi Vision 2030 to boost demand for advanced medical packaging solutions 129
11.6.1.2 UAE 130
11.6.1.2.1 Increasing demand for dietary supplements and functional foods to drive market 130
11.6.1.3 Rest of GCC countries 132
11.6.2 SOUTH AFRICA 133
11.6.2.1 Government initiatives upholding safety and efficacy standards to boost market 133
11.6.3 REST OF MIDDLE EAST & AFRICA 134
12 COMPETITIVE LANDSCAPE 136
12.1 OVERVIEW 136
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 136
12.3 REVENUE ANALYSIS 137
12.4 MARKET SHARE ANALYSIS 138
12.5 COMPANY VALUATION AND FINANCIAL METRICS 140
12.6 PRODUCT/BRAND COMPARISON ANALYSIS 142
12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 143
12.7.1 STARS 143
12.7.2 EMERGING LEADERS 143
12.7.3 PERVASIVE PLAYERS 143
12.7.4 PARTICIPANTS 143
12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 145
12.7.5.1 Company footprint 145
12.7.5.2 Form footprint 146
12.7.5.3 Material type footprint 146
12.7.5.4 Product type footprint 147
12.7.5.5 End-use industry footprint 147
12.7.5.6 Region footprint 148
12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 148
12.8.1 PROGRESSIVE COMPANIES 148
12.8.2 RESPONSIVE COMPANIES 148
12.8.3 DYNAMIC COMPANIES 149
12.8.4 STARTING BLOCKS 149
12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 150
12.9 COMPETITIVE SCENARIO AND TRENDS 152
12.9.1 PRODUCT LAUNCHES 152
12.9.2 DEALS 154
12.9.3 EXPANSIONS 156
13 COMPANY PROFILES 158
13.1 KEY PLAYERS 158
13.1.1 PFIZER INC. 158
13.1.1.1 Business overview 158
13.1.1.2 Products/Solutions/Services offered 159
13.1.1.3 Recent developments 160
13.1.1.3.1 Product launches 160
13.1.1.3.2 Deals 161
13.1.1.4 MnM view 161
13.1.1.4.1 Right to win 161
13.1.1.4.2 Strategic choices 161
13.1.1.4.3 Weaknesses & competitive threats 161
13.1.2 AMCOR PLC 162
13.1.2.1 Business overview 162
13.1.2.2 Products/Solutions/Services offered 163
13.1.2.3 Recent developments 164
13.1.2.3.1 Product launches 164
13.1.2.3.2 Expansion 165
13.1.2.4 MnM view 165
13.1.2.4.1 Right to win 165
13.1.2.4.2 Strategic choices 165
13.1.2.4.3 Weaknesses & competitive threats 165
13.1.3 CORNING INCORPORATED 166
13.1.3.1 Business overview 166
13.1.3.2 Products/Solutions/Services offered 167
13.1.3.3 Recent developments 168
13.1.3.3.1 Product launches 168
13.1.3.3.2 Deals 169
13.1.3.4 MnM view 169
13.1.3.4.1 Right to win 169
13.1.3.4.2 Strategic choices 169
13.1.3.4.3 Weaknesses & competitive threats 170
13.1.4 WEST PHARMACEUTICAL SERVICES 171
13.1.4.1 Business overview 171
13.1.4.2 Products/Solutions/Services offered 172
13.1.4.3 Recent developments 173
13.1.4.3.1 Product launches 173
13.1.4.3.2 Deals 173
13.1.4.3.3 Expansion 174
13.1.4.4 MnM view 174
13.1.4.4.1 Right to win 174
13.1.4.4.2 Strategic choices 175
13.1.4.4.3 Weaknesses & competitive threats 175
13.1.5 STEVANATO GROUP 176
13.1.5.1 Business overview 176
13.1.5.2 Products/Solutions/Services offered 177
13.1.5.3 Recent developments 178
13.1.5.3.1 Product launches 178
13.1.5.3.2 Deals 178
13.1.5.3.3 Expansion 179
13.1.5.4 MnM view 180
13.1.5.4.1 Right to win 180
13.1.5.4.2 Strategic choices 180
13.1.5.4.3 Weaknesses & competitive threats 180
13.1.6 GERRESHEIMER AG 181
13.1.6.1 Business overview 181
13.1.6.2 Products/Solutions/Services offered 182
13.1.6.3 Recent developments 183
13.1.6.3.1 Product launches 183
13.1.6.3.2 Deals 184
13.1.6.3.3 Expansion 185
13.1.6.4 MnM view 185
13.1.7 SCHOTT 186
13.1.7.1 Business overview 186
13.1.7.2 Products/Solutions/Services offered 186
13.1.7.3 Recent developments 187
13.1.7.3.1 Product launches 187
13.1.7.3.2 Deals 187
13.1.7.3.3 Expansion 188
13.1.7.4 MnM view 189
13.1.8 NIPRO 190
13.1.8.1 Business overview 190
13.1.8.2 Products/Solutions/Services offered 191
13.1.8.3 Recent developments 192
13.1.8.3.1 Product launches 192
13.1.8.4 MnM view 192
13.1.9 CONSTANTIA FLEXIBLES 193
13.1.9.1 Business overview 193
13.1.9.2 Products/Solutions/Services offered 193
13.1.9.3 Recent developments 194
13.1.9.3.1 Deals 194
13.1.9.3.2 Expansion 195
13.1.9.4 MnM view 195
13.1.10 KLOCKNER PENTAPLAST 196
13.1.10.1 Business overview 196
13.1.10.2 Products/Solutions/Services offered 196
13.1.10.3 Recent developments 197
13.1.10.3.1 Expansion 197
13.1.10.4 MnM view 197
13.2 OTHER PLAYERS 198
13.2.1 SONIC PACKAGING INDUSTRIES INC. 198
13.2.2 SHARP SERVICES, LLC 199
13.2.3 TEKNI-PLEX, INC. 200
13.2.4 THERMO-PAK CO. INC. 201
13.2.5 APHENA PHARMA SOLUTIONS 202
13.2.6 PACIFIC VIAL MANUFACTURING INC. 203
13.2.7 HEALTH CARE LOGISTICS, INC. 203
13.2.8 ULTRA SEAL CORPORATION 204
13.2.9 SAFECORE HEALTH 204
13.2.10 UNIT PACK 205
13.2.11 JONES HEALTHCARE GROUP 205
13.2.12 ROPACK INC. 206
13.2.13 RX SYSTEMS, INC. 207
13.2.14 JAMES ALEXANDER CORPORATION 208
13.2.15 PHARMACY AUTOMATION SUPPLIES 209
14 ADJACENT & RELATED MARKETS 210
14.1 INTRODUCTION 210
14.2 LIMITATIONS 210
14.2.1 PHARMACEUTICAL PACKAGING MARKET 210
14.2.1.1 Market definition 210
14.2.1.2 Pharmaceutical packaging market, by packaging type 211
14.2.1.3 Pharmaceutical packaging market, by raw material 211
14.2.1.4 Pharmaceutical packaging market, by drug delivery 213
14.2.1.5 Pharmaceutical packaging market, by type 215
14.2.1.6 Pharmaceutical packaging market, by region 217
14.2.2 NUTRACEUTICAL PACKAGING MARKET 218
14.2.2.1 Market definition 218
14.2.2.2 Nutraceutical packaging market, by product form 218
14.2.2.3 Nutraceutical packaging market, by product type 219
14.2.2.4 Nutraceutical packaging market, by packaging type 219
14.2.2.5 Nutraceutical packaging market, by material 221
14.2.2.6 Nutraceutical packaging market, by ingredient 222
14.2.2.7 Nutraceutical packaging market, by region 223
15 APPENDIX 225
15.1 DISCUSSION GUIDE 225
15.2 CUSTOMIZATION OPTIONS 228
15.3 RELATED REPORTS 228
15.4 AUTHOR DETAILS 229
LIST OF TABLES
TABLE 1 UNIT DOSE PACKAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 52
TABLE 2 WORLD GDP GROWTH PROJECTION, 2019–2026 (USD BILLION) 59
TABLE 3 AVERAGE TARIFF BY COUNTRY 63
TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 64
TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65
TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 65
TABLE 7 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 66
TABLE 8 SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 66
TABLE 9 PFIZER—ENHANCING MEDICATION COMPLIANCE IN ELDERLY PATIENTS 67
TABLE 10 WESTROCK COMPANY—IMPROVING OPERATIONAL EFFICIENCY IN UNIT DOSE PACKAGING PRODUCTION 67
TABLE 11 SHARP PACKAGING SOLUTIONS—INTEGRATING SMART TECHNOLOGY TO IMPROVE PATIENT ADHERENCE 67
TABLE 12 UNIT DOSE PACKAGING MARKET: KEY CONFERENCES & EVENTS, 2024–2025 69
TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR UNIT
DOSE PACKAGING MARKET 70
TABLE 14 KEY BUYING CRITERIA FOR TOP 3 END-USE INDUSTRIES 71
TABLE 15 UNIT DOSE PACKAGING MARKET: ROLE OF PLAYERS IN ECOSYSTEM 72
TABLE 16 PATENTS IN UNIT DOSE PACKAGING MARKET, 2022–2023 75
TABLE 17 AVERAGE SELLING PRICE OF MATERIAL TYPE, BY KEY PLAYER, 2023 (USD/TON) 79
TABLE 18 UNIT DOSE PACKAGING MARKET, BY FORM, 2022–2029 (USD BILLION) 82
TABLE 19 UNIT DOSE PACKAGING MARKET, BY MATERIAL TYPE, 2022–2029 (USD BILLION) 85
TABLE 20 UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION) 91
TABLE 21 UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY,
2022–2029 (USD BILLION) 95
TABLE 22 UNIT DOSE PACKAGING MARKET, BY REGION, 2022–2029 (USD BILLION) 100
TABLE 23 ASIA PACIFIC: UNIT DOSE PACKAGING MARKET, BY COUNTRY,
2022–2029 (USD BILLION) 102
TABLE 24 ASIA PACIFIC: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE,
2022–2029 (USD BILLION) 102
TABLE 25 ASIA PACIFIC: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY,
2022–2029 (USD BILLION) 102
TABLE 26 CHINA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE,
2022–2029 (USD BILLION) 103
TABLE 27 CHINA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY,
2022–2029 (USD BILLION) 103
TABLE 28 INDIA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE,
2022–2029 (USD BILLION) 104
TABLE 29 INDIA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY,
2022–2029 (USD BILLION) 105
TABLE 30 JAPAN: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE,
2022–2029 (USD BILLION) 105
TABLE 31 JAPAN: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY,
2022–2029 (USD BILLION) 106
TABLE 32 SOUTH KOREA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE,
2022–2029 (USD BILLION) 106
TABLE 33 SOUTH KOREA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY,
2022–2029 (USD BILLION) 107
TABLE 34 REST OF ASIA PACIFIC: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION) 107
TABLE 35 REST OF ASIA PACIFIC: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION) 108
TABLE 36 EUROPE: UNIT DOSE PACKAGING MARKET, BY COUNTRY,
2022–2029 (USD BILLION) 109
TABLE 37 EUROPE: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE,
2022–2029 (USD BILLION) 110
TABLE 38 EUROPE: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY,
2022–2029 (USD BILLION) 110
TABLE 39 GERMANY: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE,
2022–2029 (USD BILLION) 111
TABLE 40 GERMANY: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY,
2022–2029 (USD BILLION) 111
TABLE 41 FRANCE: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE,
2022–2029 (USD BILLION) 112
TABLE 42 FRANCE: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY,
2022–2029 (USD BILLION) 112
TABLE 43 ITALY: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE,
2022–2029 (USD BILLION) 113
TABLE 44 ITALY: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY,
2022–2029 (USD BILLION) 113
TABLE 45 UK: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE,
2022–2029 (USD BILLION) 114
TABLE 46 UK: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY,
2022–2029 (USD BILLION) 114
TABLE 47 SPAIN: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE,
2022–2029 (USD BILLION) 115
TABLE 48 SPAIN: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY,
2022–2029 (USD BILLION) 115
TABLE 49 REST OF EUROPE: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE,
2022–2029 (USD BILLION) 116
TABLE 50 REST OF EUROPE: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION) 116
TABLE 51 NORTH AMERICA: UNIT DOSE PACKAGING MARKET, BY COUNTRY,
2022–2029 (USD BILLION) 118
TABLE 52 NORTH AMERICA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE,
2022–2029 (USD BILLION) 119
TABLE 53 NORTH AMERICA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION) 119
TABLE 54 US: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE,
2022–2029 (USD BILLION) 120
TABLE 55 US: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY,
2022–2029 (USD BILLION) 120
TABLE 56 CANADA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE,
2022–2029 (USD BILLION) 121
TABLE 57 CANADA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY,
2022–2029 (USD BILLION) 121
TABLE 58 MEXICO: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE,
2022–2029 (USD BILLION) 122
TABLE 59 MEXICO: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY,
2022–2029 (USD BILLION) 122
TABLE 60 SOUTH AMERICA: UNIT DOSE PACKAGING MARKET, BY COUNTRY,
2022–2029 (USD BILLION) 123
TABLE 61 SOUTH AMERICA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE,
2022–2029 (USD BILLION) 123
TABLE 62 SOUTH AMERICA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION) 123
TABLE 63 BRAZIL: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE,
2022–2029 (USD BILLION) 124
TABLE 64 BRAZIL: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY,
2022–2029 (USD BILLION) 125
TABLE 65 ARGENTINA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE,
2022–2029 (USD BILLION) 126
TABLE 66 ARGENTINA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY,
2022–2029 (USD BILLION) 126
TABLE 67 REST OF SOUTH AMERICA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION) 127
TABLE 68 REST OF SOUTH AMERICA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION) 127
TABLE 69 MIDDLE EAST & AFRICA: UNIT DOSE PACKAGING MARKET, BY COUNTRY,
2022–2029 (USD BILLION) 128
TABLE 70 MIDDLE EAST & AFRICA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION) 128
TABLE 71 MIDDLE EAST & AFRICA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION) 128
TABLE 72 GCC COUNTRIES: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE,
2022–2029 (USD BILLION) 129
TABLE 73 GCC COUNTRIES: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY,
2022–2029 (USD BILLION) 129
TABLE 74 SAUDI ARABIA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE,
2022–2029 (USD BILLION) 130
TABLE 75 SAUDI ARABIA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY,
2022–2029 (USD BILLION) 130
TABLE 76 UAE: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE,
2022–2029 (USD BILLION) 131
TABLE 77 UAE: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY,
2022–2029 (USD BILLION) 131
TABLE 78 REST OF GCC COUNTRIES: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION) 132
TABLE 79 REST OF GCC COUNTRIES: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION) 133
TABLE 80 SOUTH AFRICA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE,
2022–2029 (USD BILLION) 134
TABLE 81 SOUTH AFRICA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY,
2022–2029 (USD BILLION) 134
TABLE 82 REST OF MIDDLE EAST & AFRICA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION) 135
TABLE 83 REST OF MIDDLE EAST & AFRICA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION) 135
TABLE 84 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN UNIT DOSAGE PACKAGING MARKET 136
TABLE 85 UNIT DOSE PACKAGING MARKET: DEGREE OF COMPETITION 139
TABLE 86 UNIT DOSE PACKAGING MARKET: FORM FOOTPRINT 146
TABLE 87 UNIT DOSE PACKAGING MARKET: MATERIAL TYPE FOOTPRINT 146
TABLE 88 UNIT DOSE PACKAGING MARKET: PRODUCT TYPE FOOTPRINT 147
TABLE 89 UNIT DOSE PACKAGING MARKET: END-USE INDUSTRY FOOTPRINT 147
TABLE 90 UNIT DOSE PACKAGING MARKET: REGION FOOTPRINT 148
TABLE 91 UNIT DOSE PACKAGING MARKET: KEY STARTUPS/SMES 150
TABLE 92 UNIT DOSE PACKAGING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 151
TABLE 93 UNIT DOSE PACKAGING MARKET: PRODUCT LAUNCHES,
JANUARY 2018–MAY 2024 152
TABLE 94 UNIT DOSE PACKAGING MARKET: DEALS, JANUARY 2018–MAY 2024 154
TABLE 95 UNIT DOSE PACKAGING MARKET: EXPANSIONS, JANUARY 2018–MAY 2024 156
TABLE 96 PFIZER INC.: COMPANY OVERVIEW 158
TABLE 97 PFIZER INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 159
TABLE 98 PFIZER INC.: PRODUCT LAUNCHES, JANUARY 2018−MAY 2024 160
TABLE 99 PFIZER INC.: DEALS, JANUARY 2018−MAY 2024 161
TABLE 100 AMCOR PLC: COMPANY OVERVIEW 162
TABLE 101 AMCOR PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 163
TABLE 102 AMCOR PLC: PRODUCT LAUNCHES, JANUARY 2018−MAY 2024 164
TABLE 103 AMCOR PLC: EXPANSION, JANUARY 2018−MAY 2024 165
TABLE 104 CORNING INCORPORATED: COMPANY OVERVIEW 166
TABLE 105 CORNING INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED 167
TABLE 106 CORNING INCORPORATED: PRODUCT LAUNCHES, JANUARY 2018−MAY 2024 168
TABLE 107 CORNING INCORPORATED: DEALS, JANUARY 2018−MAY 2024 169
TABLE 108 WEST PHARMACEUTICAL SERVICES: COMPANY OVERVIEW 171
TABLE 109 WEST PHARMACEUTICAL SERVICES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 172
TABLE 110 WEST PHARMACEUTICAL SERVICES: PRODUCT LAUNCHES,
JANUARY 2018−MAY 2024 173
TABLE 111 WEST PHARMACEUTICAL SERVICES: DEALS, JANUARY 2018−MAY 2024 173
TABLE 112 WEST PHARMACEUTICAL SERVICES: EXPANSION, JANUARY 2018−MAY 2024 174
TABLE 113 STEVANATO GROUP: COMPANY OVERVIEW 176
TABLE 114 STEVANATO GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 177
TABLE 115 STEVANATO GROUP: PRODUCT LAUNCHES, JANUARY 2018−MAY 2024 178
TABLE 116 STEVANATO GROUP: DEALS, JANUARY 2018−MAY 2024 178
TABLE 117 STEVANATO GROUP: EXPANSION, JANUARY 2018−MAY 2024 179
TABLE 118 GERRESHEIMER AG: COMPANY OVERVIEW 181
TABLE 119 GERRESHEIMER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 182
TABLE 120 GERRESHEIMER AG: PRODUCT LAUNCHES, JANUARY 2018−MAY 2024 183
TABLE 121 GERRESHEIMER AG: DEALS, JANUARY 2018−MAY 2024 184
TABLE 122 GERRESHEIMER AG: EXPANSION, JANUARY 2018−MAY 2024 185
TABLE 123 SCHOTT: COMPANY OVERVIEW 186
TABLE 124 SCHOTT: PRODUCTS/SOLUTIONS/SERVICES OFFERED 186
TABLE 125 SCHOTT: PRODUCT LAUNCHES, JANUARY 2018−MAY 2024 187
TABLE 126 SCHOTT: DEALS, JANUARY 2018−MAY 2024 187
TABLE 127 SCHOTT: EXPANSION, JANUARY 2018−MAY 2024 188
TABLE 128 NIPRO: COMPANY OVERVIEW 190
TABLE 129 NIPRO: PRODUCTS/SOLUTIONS/SERVICES OFFERED 191
TABLE 130 NIPRO: PRODUCT LAUNCHES, JANUARY 2018−MAY 2024 192
TABLE 131 CONSTANTIA FLEXIBLES: COMPANY OVERVIEW 193
TABLE 132 CONSTANTIA FLEXIBLES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 193
TABLE 133 CONSTANTIA FLEXIBLES: DEALS, JANUARY 2018−MAY 2024 194
TABLE 134 CONSTANTIA FLEXIBLES: EXPANSION, JANUARY 2018−MAY 2024 195
TABLE 135 KLOCKNER PENTAPLAST: COMPANY OVERVIEW 196
TABLE 136 KLOCKNER PENTAPLAST: PRODUCTS/SOLUTIONS/SERVICES OFFERED 196
TABLE 137 KLOCKNER PENTAPLAST: EXPANSION, JANUARY 2018−MAY 2024 197
TABLE 138 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE,
2020–2022 (USD MILLION) 211
TABLE 139 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE,
2023–2028 (USD MILLION) 211
TABLE 140 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL,
2020–2022 (KILOTON) 212
TABLE 141 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL,
2023–2028 (KILOTON) 212
TABLE 142 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL,
2020–2022 (USD MILLION) 212
TABLE 143 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL,
2023–2028 (USD MILLION) 213
TABLE 144 DRUG DELIVERY: PHARMACEUTICAL PACKAGING MARKET, BY REGION,
2020–2022 (USD MILLION) 213
TABLE 145 DRUG DELIVERY: PHARMACEUTICAL PACKAGING MARKET, BY REGION,
2023–2028 (USD MILLION) 214
TABLE 146 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY,
2020–2022 (USD MILLION) 214
TABLE 147 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY,
2023–2028 (USD MILLION) 215
TABLE 148 PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 216
TABLE 149 PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 216
TABLE 150 PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 217
TABLE 151 PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 217
TABLE 152 NUTRACEUTICAL PACKAGING MARKET, BY PRODUCT FORM,
2019–2022 (USD MILLION) 218
TABLE 153 NUTRACEUTICAL PACKAGING MARKET, BY PRODUCT FORM,
2023–2028 (USD MILLION) 218
TABLE 154 NUTRACEUTICAL PACKAGING MARKET, BY PRODUCT TYPE,
2019–2022 (USD MILLION) 219
TABLE 155 NUTRACEUTICAL PACKAGING MARKET, BY PRODUCT TYPE,
2023–2028 (USD MILLION) 219
TABLE 156 NUTRACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE,
2019–2022 (USD MILLION) 220
TABLE 157 NUTRACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE,
2023–2028 (USD MILLION) 220
TABLE 158 NUTRACEUTICAL PACKAGING MARKET, BY MATERIAL, 2019–2022 (USD MILLION) 221
TABLE 159 NUTRACEUTICAL PACKAGING MARKET, BY MATERIAL, 2023–2028 (USD MILLION) 221
TABLE 160 NUTRACEUTICAL PACKAGING MARKET, BY MATERIAL, 2019–2022 (KILOTON) 222
TABLE 161 NUTRACEUTICAL PACKAGING MARKET, BY MATERIAL, 2023–2028 (KILOTON) 222
TABLE 162 NUTRACEUTICAL PACKAGING MARKET, BY INGREDIENT,
2019–2022 (USD MILLION) 223
TABLE 163 NUTRACEUTICAL PACKAGING MARKET, BY INGREDIENT,
2023–2028 (USD MILLION) 223
TABLE 164 NUTRACEUTICAL PACKAGING MARKET, BY REGION, 2019–2022 (USD MILLION) 224
TABLE 165 NUTRACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 224
LIST OF FIGURES
FIGURE 1 UNIT DOSE PACKAGING: RESEARCH DESIGN 27
FIGURE 2 UNIT DOSE PACKAGING MARKET: TOP-DOWN APPROACH 32
FIGURE 3 UNIT DOSE PACKAGING MARKET: APPROACH 1 33
FIGURE 4 UNIT DOSE PACKAGING MARKET: APPROACH 2 34
FIGURE 5 UNIT DOSE PACKAGING MARKET: DATA TRIANGULATION 35
FIGURE 6 LIQUID FORM SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 39
FIGURE 7 PLASTIC SEGMENT TO WITNESS HIGHEST GROWTH RATE DURING
FORECAST PERIOD 39
FIGURE 8 BLISTER PACKS TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD 40
FIGURE 9 PHARMACEUTICALS TO BE LARGEST END-USE INDUSTRY
DURING FORECAST PERIOD 40
FIGURE 10 NORTH AMERICA TO LEAD MARKET DURING FORECAST PERIOD 41
FIGURE 11 EMERGING ECONOMIES OFFER ATTRACTIVE OPPORTUNITIES IN UNIT DOSE PACKAGING MARKET 42
FIGURE 12 US DOMINATED UNIT DOSE PACKAGING MARKET IN 2023 43
FIGURE 13 BLISTER PACKS TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 43
FIGURE 14 PHARMACEUTICALS TO LEAD UNIT DOSE PACKAGING MARKET
DURING FORECAST PERIOD 44
FIGURE 15 CHINA PROJECTED TO GROW AT HIGHEST CAGR FROM 2024 TO 2029 44
FIGURE 16 UNIT DOSE PACKAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 46
FIGURE 17 VALUE FORECAST OF PHARMACEUTICAL EMPTY CAPSULES MARKET WORLDWIDE FROM 2021 TO 2032, BY RAW MATERIALS (USD MILLION) 47
FIGURE 18 UNIT DOSE PACKAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 51
FIGURE 19 UNIT DOSE PACKAGING: VALUE CHAIN ANALYSIS 54
FIGURE 20 EXPORT OF “3923 ARTICLES FOR THE CONVEYANCE OR PACKAGING OF GOODS, OF PLASTICS; STOPPERS, LIDS, CAPS, AND OTHER CLOSURES, OF PLASTICS,” BY KEY COUNTRY, 2019–2023 55
FIGURE 21 IMPORT OF 280610 “3923 ARTICLES FOR THE CONVEYANCE OR PACKAGING
OF GOODS, OF PLASTICS; STOPPERS, LIDS, CAPS, AND OTHER CLOSURES,
OF PLASTICS,” BY KEY COUNTRY, 2019–2023 56
FIGURE 22 EMERGING TRENDS AND ADVANCEMENTS IN TECHNOLOGY TO CHANGE FUTURE REVENUE MIX OF SUPPLIERS 68
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
FOR TOP 3 END-USE INDUSTRIES 70
FIGURE 24 KEY BUYING CRITERIA FOR TOP 3 END-USE INDUSTRIES 71
FIGURE 25 UNIT DOSE PACKAGING MARKET: ECOSYSTEM 73
FIGURE 26 NUMBER OF PATENTS GRANTED FOR UNIT DOSE PACKAGING, 2013–2023 74
FIGURE 27 REGIONAL ANALYSIS OF PATENTS GRANTED FOR UNIT DOSE PACKAGING,
2013–2023 75
FIGURE 28 AVERAGE SELLING PRICE OF PHARMACEUTICAL PACKAGING, BY REGION (USD/KG) 78
FIGURE 29 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY MATERIAL TYPE (USD/KG) 79
FIGURE 30 INVESTOR DEALS AND FUNDING IN UNIT DOSE PACKAGING SOARED IN 2023 80
FIGURE 31 LIQUID SEGMENT TO REGISTER HIGHEST GROWTH THROUGH 2029 82
FIGURE 32 PLASTICS SEGMENT TO REGISTER HIGHEST CAGR THROUGH 2029 85
FIGURE 33 BLISTER PACKS SEGMENT TO RECORD HIGHEST GROWTH THROUGH 2029 91
FIGURE 34 PHARMACEUTICALS INDUSTRY TO BE LARGEST CONSUMER OF
UNIT DOSE PACKAGING 95
FIGURE 35 UNIT DOSE PACKAGING MARKET GROWTH RATE, BY COUNTRY, 2024–2029 99
FIGURE 36 ASIA PACIFIC: UNIT DOSE PACKAGING MARKET SNAPSHOT 101
FIGURE 37 EUROPE: UNIT DOSE PACKAGING MARKET SNAPSHOT 109
FIGURE 38 NORTH AMERICA: UNIT DOSE PACKAGING MARKET SNAPSHOT 118
FIGURE 39 REVENUE ANALYSIS OF KEY COMPANIES IN LAST FIVE YEARS 138
FIGURE 40 UNIT DOSE PACKAGING MARKET: MARKET SHARE ANALYSIS 139
FIGURE 41 COMPANY VALUATION (USD BILLION) 141
FIGURE 42 FINANCIAL MATRIX: EV/EBITDA RATIO 141
FIGURE 43 PRODUCT COMPARISON 142
FIGURE 44 UNIT DOSE PACKAGING MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2023 144
FIGURE 45 UNIT DOSE PACKAGING MARKET: COMPANY FOOTPRINT 145
FIGURE 46 UNIT DOSE PACKAGING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 149
FIGURE 47 PFIZER INC.: COMPANY SNAPSHOT 159
FIGURE 48 AMCOR PLC: COMPANY SNAPSHOT 163
FIGURE 49 CORNING INCORPORATED: COMPANY SNAPSHOT 167
FIGURE 50 WEST PHARMACEUTICAL SERVICES: COMPANY SNAPSHOT 172
FIGURE 51 STEVANATO GROUP: COMPANY SNAPSHOT 177
FIGURE 52 GERRESHEIMER AG: COMPANY SNAPSHOT 182
FIGURE 53 NIPRO: COMPANY SNAPSHOT 191
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11